Rare diseases
Investigational molecules
Locations
Back to Czechia574 clinical trials in Pardubice, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma
CzechiaStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
CzechiaStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis
CzechiaStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
CzechiaStudy of Pembrolizumab for Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma or Primary Mediastinal Large B-cell Lymphoma
CzechiaStudy on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation
CzechiaStudy on BI 706321 and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
CzechiaStudy of Encorafenib, Cetuximab, and Pembrolizumab for Patients with Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer
CzechiaStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
CzechiaStudy on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy
CzechiaStudy Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients
CzechiaStudy on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on vaccine development for preventable diseases, including studies of new chickenpox vaccines and advanced meningococcal vaccines for infants and children.
Research emphasizes immune response monitoring and safety assessment in young populations.
Innovative research targeting various autoimmune disorders, with studies evaluating new treatments for psoriatic arthritis and multiple sclerosis.
Trials focus on developing targeted therapies for chronic inflammatory conditions.
Studies investigating new therapeutic approaches for Parkinson's Disease and other neurological conditions, with emphasis on improving patient outcomes.
Research aims to enhance treatment options and quality of life for patients.
Advanced clinical trials focusing on prostate cancer treatment, particularly addressing metastatic castration-resistant cases.
Studies emphasize novel therapeutic approaches for advanced-stage cancers.
Research investigating treatments for osteoarthritis and joint disorders, including innovative therapies for knee-specific conditions.
Focus on developing both systemic and topical treatments for joint diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
